World's Best Scientists 2026 revealed!

D-Index & Metrics

Psychology

D-Index
48
Citations
7226
World Ranking
5996
National Ranking
3250

Armin Szegedi publication distribution in Psychology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Psychology in 2026. The highlighted bar marks where Armin Szegedi sits on this spectrum.

31–40 publications: 6 scientists 41–50 publications: 52 scientists 51–60 publications: 138 scientists 61–70 publications: 299 scientists 71–80 publications: 461 scientists 81–90 publications: 605 scientists 91–100 publications: 713 scientists 101–110 publications: 736 scientists 111–120 publications: 686 scientists 121–130 publications: 670 scientists 131–140 publications: 644 scientists 141–150 publications: 597 scientists 151–160 publications: 576 scientists 161–170 publications: 477 scientists 171–180 publications: 450 scientists 181–190 publications: 397 scientists 191–200 publications: 343 scientists 201–210 publications: 328 scientists 211–220 publications: 313 scientists 221–230 publications: 283 scientists 231–240 publications: 226 scientists 241–250 publications: 196 scientists 251–260 publications: 201 scientists 261–270 publications: 171 scientists 271–280 publications: 151 scientists 281–290 publications: 139 scientists 291–300 publications: 113 scientists 301–310 publications: 102 scientists 311–320 publications: 100 scientists 321–330 publications: 76 scientists 331–340 publications: 92 scientists 341–350 publications: 85 scientists 351–360 publications: 69 scientists 361–370 publications: 71 scientists 371–380 publications: 63 scientists 381–390 publications: 58 scientists 391–400 publications: 57 scientists 401–410 publications: 43 scientists 411–420 publications: 33 scientists 421–430 publications: 50 scientists 431–440 publications: 41 scientists 441–450 publications: 32 scientists 451–460 publications: 27 scientists 461–470 publications: 28 scientists 471–480 publications: 25 scientists 481–490 publications: 28 scientists 491–500 publications: 20 scientists 501–510 publications: 23 scientists 511–520 publications: 26 scientists 521–530 publications: 17 scientists 531–540 publications: 21 scientists 541–550 publications: 14 scientists 551–560 publications: 16 scientists 561–570 publications: 10 scientists 571–580 publications: 22 scientists 581–590 publications: 9 scientists 591–600 publications: 14 scientists 601–610 publications: 9 scientists 611–620 publications: 11 scientists 621–630 publications: 4 scientists 631–640 publications: 7 scientists 641–650 publications: 5 scientists 651–660 publications: 10 scientists 661–670 publications: 8 scientists 671–680 publications: 8 scientists 681–690 publications: 4 scientists 691–700 publications: 3 scientists 701–704 publications: 4 scientists 705+ publications: 100 scientists
31 publications 705+

This scientist: 145 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 705 publications or more.

Armin Szegedi D-index placement in Psychology in 2026

The chart shows the D-index (discipline H-index) distribution of Psychology scientists ranked by Research.com in 2026. The highlighted bar marks where Armin Szegedi sits on this spectrum.

30–31 D-Index: 398 scientists 32–33 D-Index: 702 scientists 34–35 D-Index: 671 scientists 36–37 D-Index: 659 scientists 38–39 D-Index: 641 scientists 40–41 D-Index: 671 scientists 42–43 D-Index: 617 scientists 44–45 D-Index: 558 scientists 46–47 D-Index: 495 scientists 48–49 D-Index: 487 scientists 50–51 D-Index: 445 scientists 52–53 D-Index: 390 scientists 54–55 D-Index: 408 scientists 56–57 D-Index: 345 scientists 58–59 D-Index: 325 scientists 60–61 D-Index: 321 scientists 62–63 D-Index: 248 scientists 64–65 D-Index: 290 scientists 66–67 D-Index: 218 scientists 68–69 D-Index: 219 scientists 70–71 D-Index: 215 scientists 72–73 D-Index: 183 scientists 74–75 D-Index: 169 scientists 76–77 D-Index: 132 scientists 78–79 D-Index: 137 scientists 80–81 D-Index: 120 scientists 82–83 D-Index: 112 scientists 84–85 D-Index: 86 scientists 86–87 D-Index: 101 scientists 88–89 D-Index: 83 scientists 90–91 D-Index: 77 scientists 92–93 D-Index: 70 scientists 94–95 D-Index: 78 scientists 96–97 D-Index: 58 scientists 98–99 D-Index: 53 scientists 100–101 D-Index: 57 scientists 102–103 D-Index: 48 scientists 104–105 D-Index: 53 scientists 106–107 D-Index: 46 scientists 108–109 D-Index: 24 scientists 110–111 D-Index: 35 scientists 112–113 D-Index: 27 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 31 scientists 118–119 D-Index: 22 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 24 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 11 scientists 128–129 D-Index: 19 scientists 130–131 D-Index: 10 scientists 132–133 D-Index: 16 scientists 134–135 D-Index: 10 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 5 scientists 142–143 D-Index: 12 scientists 144+ D-Index: 98 scientists
30 D-Index 144+

This scientist: 48 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 144 D-Index or more.

Overview

Armin Szegedi is affiliated with MSD (United States) and is active in research primarily within the field of Medicine. Their work spans several subfields including Psychiatry and Mental Health, Pathology and Forensic Medicine, Sensory Systems, and Surgery. The main research focus is on migraine and headache studies, with considerable contributions to trigeminal neuralgia and treatments as well as psychosomatic disorders and related therapeutic approaches.

Their scholarly output includes research on olfactory and sensory function studies, cardiovascular syncope and autonomic disorders, and historical and scientific studies. Szegedi's research has been published frequently in the following venues:

  • Neurology
  • The Lancet Neurology
  • Headache The Journal of Head and Face Pain
  • Cephalalgia

Significant recent papers by Szegedi include:

  • Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial, 2020, The Lancet Neurology
  • Efficacy of ubrogepant based on prior exposure and response to triptans: A post hoc analysis, 2021, Headache The Journal of Head and Face Pain
  • Time course of efficacy of ubrogepant for the acute treatment of migraine: Clinical implications, 2020, Cephalalgia
  • Efficacy Is Maintained With Long-term Intermittent Use of Ubrogepant for the Acute Treatment of Migraine (111), 2020, Neurology
  • Ubrogepant Achieves Onset of Pain Relief at 1 Hour for the Acute Treatment of Migraine (1223), 2020, Neurology

The researcher has collaborated frequently with several coauthors including Joel M. Trugman, Peter J. Goadsby, David W. Dodick, Kaifeng Lu, and Michelle Finnegan. These partnerships have contributed to multiple publications and research projects, particularly in the study and treatment of migraine and headache.

The number of publications and citations suggests ongoing engagement with clinical and therapeutic aspects of migraine treatment. Although there are no listed book publications or awards, the focus on relevant clinical trials and analyses defines Szegedi's contributions to the field.

Best Publications

  • Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients.

    Armin Szegedi;Wim T. Jansen;Arjen P. P. van Willigenburg;Egbert van der Meulen

  • Differentiating moderate and severe depression using the Montgomery-Asberg depression rating scale (MADRS).

    Matthias J. Müller;Hubertus Himmerich;Barbara Kienzle;Armin Szegedi

  • Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine.

    A Szegedi;R Kohnen;A Dienel;M Kieser

  • Confirmation of association of the GABRA2 gene with alcohol dependence by subtype-specific analysis.

    Christoph Fehr;Thomas Sander;Andre Tadic;Kirsten P. Lenzen

  • Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression.

    Armin Szegedi;Matthias J Müller;Ion Anghelescu;Christoph Klawe

  • What does the HAMD mean

    Stefan Leucht;Hein Fennema;Rolf Engel;Marion Kaspers-Janssen

  • The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression.

    A Szegedi;D Rujescu;A Tadic;M J Müller

  • Mirtazapine Compared With Paroxetine in Major Depression

    Otto Benkert;Armin Szegedi;Ralf Kohnen

  • Pharmacokinetic Interactions of Clozapine With Selective Serotonin Reuptake Inhibitors: Differential Effects of Fluvoxamine and Paroxetine in a Prospective Study

    Hermann Wetzel;Ion Anghelescu;Armin Szegedi;Jasmin Wiesner

  • Is There a Common Resilience Mechanism Underlying Antidepressant Drug Response? Evidence From 2848 Patients

    Hans H. Stassen;Jules Angst;Daniel Hell;Christian Scharfetter

  • Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression.

    A. Tadic;D. Rujescu;A. Szegedi;I. Giegling

  • Moderate and severe depression: Gradations for the Montgomery–Åsberg Depression Rating Scale

    Matthias J Müller;Armin Szegedi;Hermann Wetzel;Otto Benkert

  • Systematic analysis of glutamatergic neurotransmission genes in alcohol dependence and adolescent risky drinking behavior.

    Gunter Schumann;Monika Johann;Josef Frank;Ulrich Preuss

  • Superior efficacy of St John's wort extract WS®5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298]

    Siegfried Kasper;Ion-George Anghelescu;Armin Szegedi;Angelika Dienel

  • Combination treatment with clomipramine and fluvoxamine: drug monitoring, safety, and tolerability data.

    A Szegedi;H Wetzel;M Leal;S Härtter

  • Reliability and validity of the German version of the European Addiction Severity Index (EuropASI).

    A Scheurich;M J Müller;H Wetzel;I Anghelescu

  • Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome.

    Florian Muller-Siecheneder;Matthias J. Muller;Andreas Hillert;Armin Szegedi

  • The HTR1B 861G>C receptor polymorphism among patients suffering from alcoholism, major depression, anxiety disorders and narcolepsy

    Christoph Fehr;Nina Grintschuk;Armin Szegedi;Ion Anghelescu

  • A Randomized Placebo-Controlled Trial of Asenapine for the Prevention of Relapse of Schizophrenia After Long-Term Treatment

    John M. Kane;Mary Mackle;Linda Snow-Adami;Jun Zhao

  • Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension.

    Armin Szegedi;Joseph R. Calabrese;Let Stet;Mary Mackle

  • An overview of the clinical efficacy of mirtazapine.

    O. Benkert;M. Muller;A. Szegedi

Frequent Co-Authors

Otto Benkert
Otto Benkert Johannes Gutenberg University of Mainz
Dan Rujescu
Dan Rujescu Medical University of Vienna
Ina Giegling
Ina Giegling Martin Luther University Halle-Wittenberg
Michael Soyka
Michael Soyka Ludwig-Maximilians-Universität München
Thomas Sander
Thomas Sander University of Cologne
Jules Angst
Jules Angst University of Zurich
Rainer Spanagel
Rainer Spanagel Heidelberg University
Karl Mann
Karl Mann Heidelberg University
Michael E. Thase
Michael E. Thase University of Pennsylvania
H.-J. Möller
H.-J. Möller Ludwig-Maximilians-Universität München

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a Psychology degree in the USA opens a range of online program options and career directions, especially in the counseling profession. Many accredited universities offer flexible online degrees that lead to careers in counseling, mental health, and related fields.

If your goal is to start working as a counselor quickly, there are several streamlined educational pathways. For example, the quickest path to becoming a counselor in Connecticut emphasizes targeted graduate programs and state-specific licensure requirements. Similarly, if you want information on the shortest path to becoming a counselor in Delaware, you'll find routes focused on fulfilling supervision hours and coursework efficiently.

For students in the Southeast, understanding the quickest path to becoming a counselor in Florida could accelerate your transition into the profession through online and hybrid formats. Those interested in regional differences and innovative approaches should explore Georgia accelerated counseling programs.

No matter which state you choose, online study, careful course selection, and awareness of state licensure processes will help maximize your career opportunities in psychology-related fields.

Best Scientists Citing Armin Szegedi

Trending Scientists

Recently Published Articles